Institutional investors control 0.93% of the outstanding shares in BAYRY. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Other industry. Additionally, during the quarter ended September 2017, these large investors purchased a net $2.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARK INVESTMENT MANAGEMENT LLC Bought 380.00 shares of Bayer AG